BISOPROLOL-HYDROCHLOROTHIAZIDE 5-6.25 MG TAB

Bisoprolol Fumarate and Hydrochlorothiazide
$0.2159per EA
High Outlier

Strength

5; 6.25 mg/1; mg/1

NDC

70954041340

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

8/20/2025

Approval Type

Generic (ANDA)

FDA Application

ANDA215562

On Market Since

11/4/2021

Pharmacological Classes

Adrenergic beta-Antagonists
Increased Diuresis
Thiazide Diuretic
Thiazides
beta-Adrenergic Blocker

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

+5.2%

3Y

-22.4%

5Y

N/A

All

-30.9%